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Background: Increased incidence of bacterial pneumonia (BP) has been reported in IrishWolfhounds
(IWHs), and recurrence of BP is common. The etiology of recurrent pneumonia in IWHs is largely
unknown.
Objectives: To describe clinical findings in IWHs with recurrent BP and investigate possible
etiologies.
Animals: Eleven affected IWHs, 25 healthy IWHs, 28 healthy dogs of other Sighthound breeds,
and 16 healthy dogs of other breeds.
Methods: Prospective cross-sectional observational study. All affected IWHs underwent thor-
ough clinical examinations including thoracic radiographs, thoracic computed tomography, elec-
tron microscopic evaluation of ciliary structure, and bronchoscopy and bronchoalveolar lavage
fluid (BALF) cytology and culture. Serum and BALF immunoglobulin concentrations were mea-
sured using an ELISA method, and peripheral blood lymphocyte subpopulations were analyzed
using flow cytometry. Esophageal function was assessed by fluoroscopy (n = 2).
Results: Median age of onset was 5.0 years (range, 0.4-6.5 years), and when presented for
study, dogs had experienced a median of 5 previous episodes of BP (range, 2-6). The following
predisposing factors to BP were detected: focal bronchiectasis (10/11), unilateral (2/9) and bilat-
eral (1/9) laryngeal paralysis, and esophageal hypomotility (2/2). Local or systemic immunoglob-
ulin deficiencies or primary ciliary defects were not detected.
Conclusions and Clinical Importance: Recurrent BP affects mostly middle-aged and older IWHs
without any evident immune deficit or primary ciliary defects. Focal BE was a frequent finding
in affected dogs and likely contributed to the development of recurrent respiratory infections.
Laryngeal and esophageal dysfunction identified in a minority of dogs may contribute to
recurrent BP.
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1 | INTRODUCTION
Bacterial pneumonia (BP) is an acquired inflammation of the lower air-
ways and lung parenchyma caused by bacterial infection.1,2 Physiologi-
cal protective mechanisms in the lungs are relatively effective, and the
development of BP usually requires either a large number of bacteria or
impaired pulmonary defenses.1 Bronchopneumonia most often is
caused by opportunistic bacteria belonging to the normal oropharyngeal
Abbreviations: BA, bronchoarterial; BALF, bronchoalveolar lavage fluid; BE,
bronchiectasis; BP, bacterial pneumonia; cfu, colony forming unit; CT, computed
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flora, which emphasizes the importance of predisposing factors in the
development of BP.3–5 Several predisposing factors to the development
of BP have been described in dogs, including infections with respiratory
viruses, ciliary defects, an immune deficit, and conditions predisposing
to aspiration, such as laryngeal dysfunction, decreased esophageal motil-
ity, recent anesthesia, or neurological disease.3,6–18
An increased incidence of BP has been reported in the Irish Wolf-
hound (IWH), and recurrent BP has been identified frequently in this
breed.19–21 A recent questionnaire-based study described at least 1 epi-
sode of pneumonia in 37% of IWHs, and the majority of these dogs
(53%) experienced recurrent episodes.19 Bronchopneumonia is also 1
of the most common causes of death in IWHs along with neoplasia, car-
diac disease, and musculoskeletal disorders.19,22–24 Additionally, a sig-
nificantly shorter life span has been reported in IWHs with a history of
pneumonia, indicating that episodes of BP are severe in this breed, and
death as a consequence of BP is a notable problem.19
The etiology of this breed predisposition is not well established. A
retrospective study suggested aspiration as an etiology based on the
acute onset of respiratory signs and radiographic changes in the depen-
dent lung lobes.20 However, a predisposing factor to aspiration was iden-
tified only in a minority (16%) of IWHs.20 Supporting aspiration as a
possible etiology, another study reported megaesophagus in a small
number (9%) of IWHs with recurrent BP.19 To our knowledge, prospec-
tive studies examining the etiology of recurrent BP in IWHs are lacking.
A unique rhinitis and bronchopneumonia syndrome (RBPS) has
been described in young IWHs and is characterized by variable rhinor-
rhea present mostly from birth, accompanied by recurrent BP.25–27
The clinical picture of RBPS resembles primary ciliary dyskinesia or
primary immune deficiency.25 These diseases have not been identified
in affected dogs, but the possibility of immunoglobulin A (IgA) defi-
ciency has been suggested.25,28 Pedigree analysis of IWHs with RBPS
has identified shared ancestors, suggesting a hereditary component in
this disease.25 Currently, it is still unclear whether recurrent BP in
IWHs represents a disease entity distinct from RBPS.
Our aim was to describe the clinical as well as diagnostic imaging fea-
tures in IWHs with recurrent BP and to investigate possible etiologies.
2 | MATERIALS AND METHODS
2.1 | Study design
This study was conducted as a prospective cross-sectional observa-
tional study.
2.2 | Study population
Privately owned IWHs referred for examinations to the Veterinary
Teaching Hospital of the University of Helsinki between March 2014
and March 2017 because of recurrent episodes of BP (≥2 episodes)
were eligible for inclusion. Dogs were included in the study only
between pneumonia episodes when they were clinically healthy and
not receiving antimicrobial treatment.
As healthy controls, privately owned healthy IWHs >6 years
of age with no history or clinical findings suggestive of previous or
current BP, as well as dogs of other Sighthound breeds and dogs of
various other breeds, were recruited as healthy controls. These dogs
had no clinical signs of illness and had normal physical examination
findings as well as normal hematology and serum biochemistry find-
ings. Additionally, 6 healthy purpose-bred laboratory Beagle dogs
(normal physical examination findings, blood hematology, serum bio-
chemistry and arterial blood gas analysis results, unremarkable tho-
racic radiographs and bronchoscopy findings, as well as a negative
bacterial culture in bronchoalveolar lavage fluid [BALF]) were included
as healthy controls for BALF comparisons.
2.3 | History and follow-up information
Information concerning age of onset, number of previous episodes of
BP, and possible clinical signs and medications between BP episodes
was gathered from owners of affected IWHs using a questionnaire.
Additionally, a separate questionnaire describing clinical signs, diagnos-
tic tests, medications, and treatment responses during each separate
episode of BP was completed by the owners. Referring veterinarians
were contacted and patient records and radiographs were evaluated
retrospectively to verify the diagnosis.
Owners were contacted by phone 1 year after the study end
point (April 2018) and information concerning further episodes of BP
as well as the time and cause of death if applicable was documented.
2.4 | Diagnostic testing and sample collection
All dogs underwent a full clinical examination, and venous blood sam-
ples for hematology, serum biochemistry, immunoglobulin measure-
ments, and lymphocyte differentiation were obtained. Additionally, in
IWHs with recurrent BP and in healthy laboratory Beagles, thoracic
radiographs (left and right laterolateral and ventrodorsal views) and
fecal samples (3 consecutive days) were obtained, and arterial blood
gas analysis for partial pressures of oxygen (PaO2), carbon dioxide
(PaCO2), and alveolar-arterial oxygen gradient was performed. Laryn-
geal evaluation was performed in IWHs with recurrent BP under light
anesthesia after IV butorphanol (Butordol 10 mg/mL, Intervet Interna-
tional B.V., Boxmeer, the Netherlands) and propofol (PropoVet Multi-
dose 10 mg/mL, Fresenius Kabi AB, Uppsala, Sweden). Movement of
the arytenoid cartilages was observed until either normal movement
was observed or the dog was too awake to tolerate the examina-
tion.29 Thoracic computed tomography (CT) was performed under
general anesthesia in intubated patients during an expiratory pause
with a helical scanner (Somatom Emotion Duo, Siemens Germany, and
GE LightSpeed VCT 64, GE Healthcare, Fairfield, Connecticut). The CT
examination was performed first in a dorsal recumbency and then in ven-
tral recumbency. After the CT examination, bronchoscopy was performed
with the dog in ventral recumbency using a 4.9-mm flexible endoscope
(GIF-N180, Olympus Europa SE&Co. KG, Hamburg, Germany), and air-
way samples for cytology and semiquantitative bacterial culture were
obtained by weight adjusted bronchoalveolar lavage (BAL).30 After BAL,
ciliary biopsy specimens were obtained from the distal trachea using a
single-use endoscopic biopsy forceps, placed into a buffered glutaralde-
hyde solution, and shipped to a veterinary diagnostic pathology service
(University of Liverpool, Neston, UK) for electron microscopy.
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Evaluation of esophageal function was performed at a separate
appointment by a fluoroscopic (BV Libra C-arm, Philips Medical Sys-
tems, Eindhoven, the Netherlands) swallow study using barium sulfate
(Mixobar Colon 1 g/mL, Bracco Imaging S.p.A, Colleretto Giacosa,
Italy) mixed in canned food (1:10) for those dogs in which signs sug-
gestive of esophageal dysfunction were identified in the history or
during the aforementioned investigations. The study was performed
in awake standing animals.
Thoracic radiographs and CT images were assessed by the same
radiologist (A.K.L), who was blinded to the patient data. The presence
and severity of bronchiectasis (BE) was assessed by using previously
established criteria.31 Each lung lobe was assessed for the presence of
bronchiectasis (BE) using transverse images, and bronchoarterial
(BA) ratio was measured at several locations including at least 1 nor-
mal-appearing central and peripheral airway in each lung lobe as well
as all abnormally wide-appearing airways. The largest BA ratio was
recorded for each lung lobe.
2.5 | Sample handling and analysis
Hematology, serum biochemistry, arterial blood gas, and fecal analysis as
well as with cytological evaluation and bacterial cultures of respiratory
samples (semiquantitative aerobic bacterial culture and Mycoplasma spp.
culture) were performed as previously described.32 Swab samples were
obtained from mucosal membranes (oral mucosa, nares, and perineum)
to screen for methicillin-resistant Staphylococcus pseudintermedius
(MRSP) colonization and were processed as described previously.33
Serum and BALF samples obtained for immunoglobulin analysis
were frozen immediately and stored at −80C until analysis.34
Immunoglobulin A, M, and G (IgA, IgM, and IgG) were measured in serum
and in BALF with ELISA kits for canine samples (Bethyl Laboratories Inc.,
Montgomery, Texas).35–37 Serum and BALF urea concentrations were
measured with a clinical chemistry analyzer (Kone Specific, Thermo
Fisher Scientific, Vantaa, Finland) by using an enzymatic method (UREA
UV 250, bioMérieux SA, Marcy l'Etoile, France), and the proportion of
epithelial lining fluid (ELF) in the BALF was calculated as follows using
serum and BALF urea measurements: proportion of ELF = (concentra-
tion of urea in BALF / concentration of urea in serum) × 100% as
described previously.30 Epithelial lining fluid immunoglobulin concentra-
tions were calculated by using the known proportion of ELF in BALF.
Fresh EDTA blood samples were stained with monoclonal anti-
bodies to canine lymphocyte cell surface antigens (fluorescent mouse/rat
anti-dog CD3, CD4, CD8, CD21, and MHC class II antibodies) as
described previously (AbD Serotec, Oxford, United Kingdom).38,39
Briefly, 100 μL aliquots of fresh EDTA blood were exposed to 3 different
combinations of antibodies (tube 1: antiCD3 [FITC], antiCD4 [PE], and
antiCD8 [AlexaFluor 647]; tube 2: antiCD3 [FITC] and antiCD21 [PE];
and tube 3: AntiMHC class II [FITC] and antiCD21 [PE]). Five microliter
of each antibody was used. A 4th 100 μL aliquot of EDTA blood was not
exposed to antibodies. Additionally, aliquots of EDTA blood were stained
with each single antibody separately and used as controls. Tubes were
incubated for 30 minutes in the dark, and red blood cells were lysed with
a commercial erythrocyte lysing buffer (Erythrolyse Red Blood Cell Lys-
ing Buffer, AbD Serotec, Oxford, United Kingdom). Cells were washed
with a washing solution (phosphate-buffered saline with 1% bovine
serum albumin) and 0.4% paraformaldehyde was used as a cell-fixing
solution.40 Samples were analyzed within 48 hours of staining with a BD
FACSAria II flow cytometer (BD Biosciences, San Jose, California) and
BD FACSDiva software (BD Biosciences, San Jose, California). Lympho-
cytes were identified using an electronic gate based on cell size and gran-
ularity (forward and side-angle light scatter properties). A minimum of
50 000 events was recorded for each preparation. Absolute concentra-
tions of lymphocyte subpopulations were calculated by hematology anal-
ysis results in combination with flow cytometry data.
2.6 | Statistical analysis
Normality testing was performed by the Shapiro-Wilk test of normality
and normal Q-Q plots. Differences in response variables (hematology
results, serum immunoglobulin measurements, and lymphocyte flow
cytometry results) among groups (affected IWHs, healthy IWHs,
healthy Sighthounds, and healthy dogs of other breeds) were analyzed
separately using analysis of covariance (ANCOVA) models. Different trans-
formations (logarithmic, square root, and rank) were made for the
response variables to satisfy the normality assumption of the ANCOVA
models. Two separate models were fitted for each response variable:
(1) model with age-covariate dog group as fixed factor and an interac-
tion term between age and the dog group, and (2) model with only the
main effects of the age-covariate and the dog group. Estimates were
calculated for differences between relevant groups for the main effects
models.
Differences in BALF parameters and arterial blood gas analysis
results between affected IWHs and healthy laboratory Beagles were
evaluated by the independent samples Student's t test (normally distrib-
uted variables) and the Mann-Whitney U test (non-normally distributed
variables). All statistical analyses were performed by commercial statis-
tical software (PASW Statistics 18, SPSS Inc., Chicago, Illinois; and SAS
System for Windows 9.3, SAS Institute Inc., Cary, North Carolina).
P values <.05 were considered statistically significant.
2.7 | Ethical approval and owner consent
The study was approved by the University of Helsinki, Viikki Campus
Research Ethics Committee (Statement 2/2014). Owner consent was
obtained from the owners of the dogs before participation. The use of
purpose-bred laboratory Beagles (decision ESLH-2008-05403/Ym-23,
annex ESAVI-2010-03587/Ym-23) and blood sampling in healthy pri-
vately owned dogs (decision ESAVI-9116-04.10.07/2014) were
approved by the Board of Animal Experimentation of the Regional
State Administrative Agency of Southern Finland. Animals were cared
for according to the principles outlined by national laws and regula-
tions on laboratory animals.
3 | RESULTS
3.1 | Dogs
Eleven IWHs with recurrent BP, as well as 25 healthy IWHs without a
history of previous BP, 28 healthy dogs of other Sighthound breeds,
and 16 healthy dogs of other breeds were included in the study. Age,
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body weight, and sex distribution of the dogs are presented in
Table 1. Dogs of other Sighthound breeds consisted of 21 Whippets,
2 Greyhounds, 2 Borzois, and 1 Afghan Hound, Hungarian Grey-
hound, and Polish Greyhound. Dogs of non-Sighthound breeds repre-
sented various breeds.
All IWHs with recurrent BP were examined between episodes
of BP when they were clinically healthy. At the time of inclusion,
1 dog was receiving prednisolone (0.08 mg/kg PO q24h) and 3 dogs
were receiving pain medication for orthopedic problems (carprofen,
mavacoxib, and gabapentin).
Affected IWHs had experienced their first BP at a median age of
5.0 years (range, 0.4-6.5 years), and when presented to the study, the
dogs had experienced a median of 5 previous episodes of BP (range,
2-6). The dogs had experienced recurrence of BP at a mean interval of
3 months (interquartile range, 1.8-5.5 months; range, 1.3-8 months).
Most owners (6/11) considered their dogs to be free of respiratory
signs between episodes of BP. Five dogs were reported to cough reg-
ularly (1/5, daily; 3/5, weekly; 1/5, monthly). Mild exercise intolerance
was reported by 6/11 owners, 3 of whom reported concurrent ortho-
pedic problems. None of the owners reported inspiratory wheezes
during exercise. One dog was reported to regurgitate daily and 1 dog
was reported to eructate daily and regurgitate occasionally.
Owners of affected IWHs reported altogether 47 episodes of pre-
vious BP. All episodes of BP had an acute onset of clinical signs,
including tachypnea (47/47), dyspnea (46/47), fever (43/47), cough
(37/47), breathing with an extended neck (13/47), unwillingness to lie
down (10/47), serous nasal discharge (8/47), purulent nasal discharge
(2/47), and sneezing (2/47). In the majority of BP episodes (45/47),
rapid recovery was reported after initiation of antimicrobial treatment.
In 2 episodes of BP, the owners reported that the first antimicrobial
was changed to another before clinical signs were relieved. Owners
reported full recovery in 43/47 episodes of BP. In 2 episodes of BP,
clinical signs relapsed immediately after antimicrobials were discontin-
ued and in 2 episodes of BP, a mild cough persisted afterward.
3.2 | Review of patient records and radiographs
Patient records and radiographs from referring veterinarians were
available from 8/11 dogs for retrospective review. In the remaining
3/11 dogs, the referring veterinarian had established a diagnosis of
BP, and the acute onset of clinical signs (fever, tachypnea, dyspnea,
and cough) as well as rapid response to antimicrobial treatment were
highly supportive of the diagnosis. Radiographs were obtained at the
referring veterinarian in 17/47 episodes of previous BP. Especially
when BP recurred frequently, the diagnosis was based on typical clini-
cal signs and increased serum C-reactive protein concentration.32
3.3 | Clinical findings
Clinical examination findings included normal respiratory rate and
character of breathing in all dogs. Lung auscultation was normal in
9/11 dogs and mild crackles were detected ventrally in 2/11 dogs.
None of the dogs coughed spontaneously, and a mild cough was pro-
voked by tracheal palpation in 5/11 dogs. Cardiac auscultation, heart
rate, and rhythm were normal in all dogs.
The results of blood hematology are presented in Table 1. Arterial
blood gas analysis results are presented in Table 2. Fecal analyses
were negative for lungworms and intestinal parasites in all Beagles
and IWHs with recurrent BP. Three of 11 of the affected IWHs were
found to be carriers of MRSP in their mucosal membranes.
TABLE 1 Demographic variables as well as the results of hematology and serum immunoglobulin (Ig) analysis in Irish Wolfhounds (IWHs) with
recurrent bacterial pneumonia, in healthy IWHs, in healthy Sighthounds, and in healthy dogs of other breeds
Median (IQR)
IWHs with recurrent
bacterial pneumonia
n = 11
Healthy IWHs
n = 25
Healthy Sighthounds
n = 28
Healthy dogs
of other breeds
n = 16
Age (years) 6.3 (5.7-7.0) 6.6 (6.3-8.9) 6.8 (5.3-8.7) 6.5 (5.7-10.4)
Sex Male 3/11 Male 7/25 Male 15/28 Male 3/16
Female 8/11 Female 18/25 Female 13/28 Female 13/16
Body weight (kg) 63.9 (58.6-71.3) 64.2 (56.0-70.0) 19.9 (14.8-33.1)*** 29.2 (7.6-36.7)***
Blood hematology
Leukocyte count (109/L) 7.9 (7.2-8.6) 7.2 (5.5-8.2) 5.7 (4.9-6.1)*** 7.6 (6.3-9.8)
Segmented neutrophil count (109/L) 5.8 (4.5-7.0) 5.1 (3.5-5.9) 3.6 (3.0-4.6)*** 4.3 (3.7-6.4)
Lymphocyte count (109/L) 1.3 (1.1-1.7) 1.2 (1.0-1.6) 1.2 (1.0-1.7) 2.3 (2.0-2.6)***
Eosinophil count (109/L) 0.07 (0.02-0.2) 0.08 (0.03-0.3) 0.2 (0.1-0.5) 0.6 (0.3-0.9)**
Monocyte count (109/L) 0.5 (0.3-0.9) 0.5 (0.2-0.9) 0.2 (0.2-0.3)*** 0.3 (0.2-0.6)
Basophil count (109/L) 0.01 (0.0-0.02) 0.01 (0.01-0.02) 0.01 (0.01-0.01) 0.02 (0.01-0.02)
Serum immunoglobulin concentration
IgA (mg/dL) 104.8 (76.0-238.6) 137.7 (92.5-168.5) 87.3 (54.5-125.4)* 125.1 (75.9-226.9)
IgG (mg/dL) 1000.4 (858.3-1368.0) 1227.0 (965.9-1482.5) 1349.5 (1042.8-1570.3) 1164.0 (930.8-1266.3)
IgM (mg/dL) 317.4 (251.1-378.3) 296.5 (220.0-404.1) 145.8 (131.9-219.6)*** 187.9 (164.8-295.3)*
Abbreviation: IQR, interquartile range.
*Significantly different compared with affected IWHs P < .05. **Significantly different compared with affected IWHs P < .01. ***Significantly different
compared with affected IWHs P < .001.
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3.4 | Immunoglobulin measurements
Serum immunoglobulin measurements (IgA, IgG, and IgM) were avail-
able for all dogs. Immunoglobulin concentrations did not differ signifi-
cantly between affected IWHs and healthy IWHs (Table 1). Age
significantly affected serum IgA concentrations in all dogs when statis-
tically examined as 1 group (P < .001): older animals had higher serum
IgA concentrations.
Epithelial lining fluid immunoglobulin concentrations did not differ
significantly between affected IWHs and healthy laboratory Beagles
(Table 2).
3.5 | Lymphocyte subpopulations
Flow cytometry analysis was performed in all affected IWHs, in 23/25
healthy IWHs, in 23/28 healthy Sighthounds, and in all healthy dogs
of other breeds. In all dogs (when statistically examined as 1 group),
the percentage and the absolute concentration of CD8+ lymphocytes
as well as the CD4/CD8 ratio were significantly affected by age: older
dogs had significantly more CD8+ lymphocytes (P = .005) and a signif-
icantly lower CD4/CD8 ratio (P < .001). The results of flow cytometry
analysis are presented in Table 3.
3.6 | Imaging findings
A mild to moderate bronchial or bronchointerstitial pattern was the
most frequent finding in thoracic radiographs in 8/11 affected IWHs.
Cranial and ventral lung lobes were affected most commonly. A focal
alveolar pattern was detected in 2 dogs (in the right cranial lung lobe
in 1 dog and in the caudal segment of the left cranial lung lobe in the
other dog). Bronchiectasis was not detected in any of the thoracic
radiographs. Abnormal accumulation of air in the esophagus was not
detected in any of the dogs. Cardiac size was considered normal in all
affected IWHs (vertebral heart scale mean, 9.0; SD, 0.5).41
Bronchiectasis was the most common abnormality detected in CT
images of 10/11 affected IWHs (Figure 1). The location, distribution,
and type of BE are presented in Table 4. Other CT findings consisted
of local mildly to moderately increased attenuation and thickened
bronchial walls (2/11), parenchymal band (2/11), local mildly increased
attenuation (1/11), focal reticular pattern (1/11), locally thickened
pleura (1/11), and subpleural band (1/11).
3.7 | Bronchoscopy and respiratory sampling
Bronchoscopic abnormalities were detected in 10/11 affected IWHs
(Figure 2) and consisted of mild to moderate bronchial mucosal irregu-
larity (10/11), small amount of bronchial secretions (4/11), mild to
moderate BE (4/11), and local bronchomalacia (3/11). Bronchoscopic
changes were most prevalent in cranial and ventral lung lobes.
Results of BALF cytology analysis are presented in Table 3. The
BALF bacterial cultures were negative in all Beagles and in 9/11
affected IWHs. In 1 dog, Streptococcus canis (102 colony forming units
[cfu]/mL) and S. pseudintermedius (102 cfu/mL) were detected, and
Klebsiella pneumoniae (102 cfu/mL) was detected in another. The
BALF cytology did not support bacterial infection in either of these
dogs. The Mycoplasma spp. culture was negative in all affected IWHs.
3.8 | Electron microscopy of ciliary biopsies
Changes indicating primary ciliary dyskinesia were not observed in
any of the affected IWHs (Figure 3). Small numbers of compound cilia
TABLE 2 Arterial blood gas analysis, bronchoalveolar lavage fluid (BALF) cytology, and epithelial lining fluid (ELF) immunoglobulin measurement
results in Irish Wolfhounds (IWHs) with recurrent bacterial pneumonia and in healthy laboratory Beagles
Mean ± SD or median (IQR)
IWHs with recurrent
bacterial pneumonia
n = 11
Healthy Beagle dogs
n = 6 P value
Arterial blood gas analysis
Arterial PaO2 mmHg 95.2 ± 4.7 95.4 ± 4.9 .84
Arterial PaCO2 mmHg 29.6 ± 3.2 33.2 ± 2.2 .04
Alveolar-arterial O2 gradient 19.8 ± 3.5 16.8 ± 3.6 .16
BALF analysis
Total cell count (109/L) 0.31 (0.17-0.47) 0.26 (0.21-0.32) .88
Neutrophils (%) 4.4 (1.7-5.7) 2.9 (2.2-3.5) .40
Eosinophils (%) 1.4 (0.0-2.4) 1.2 (0.6-1.4) .96
Mast cells (%) 0.7 ± 0.8 1.8 ± 1.1 .05
Lymphocytes (%) 25.1 ± 10.7 18.8 ± 7.9 .13
Macrophages (%) 61.1 ± 16.0 73.9 ± 9.6 .11
Epithelial cells (%) 0.0 (0.0-0.0) 0.6 (0.0-3.8) .06
Proportion of ELF in respiratory samples (%) 3.2 ± 1.3 2.1 ± 0.9 .10
Respiratory sample immunoglobulin concentration
ELF immunoglobulin A (mg/dL) 18.6 (9.6-48.5) 20.9 (17.7-42.3) .46
ELF immunoglobulin G (mg/dL) 57.7 (31.5-131.4) 68.7 (59.6-127.1) .64
ELF immunoglobulin M (mg/dL) 2.3 (1.4-4.2) 1.3 (0.0-12.1) .40
Abbreviations: IQR, interquartile range; PaCO2, partial pressure of arterial carbon dioxide; PaO2, partial pressure of arterial oxygen.
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(<10% of examined cilia) were detected in 10/11 dogs. Additionally,
rod-shaped bacteria were detected on the luminal aspect of cells in
1 dog that had negative bacterial culture in BALF.
3.9 | Laryngeal and esophageal function
Laryngeal function was evaluated in 9/11 dogs. Normal function was
observed in 6/9 dogs, 2 dogs had unilateral laryngeal paresis (grade 2),
and bilateral laryngeal paralysis (grade 3) was diagnosed in 1 dog.29
None of the affected IWHs had findings suggestive of megaeso-
phagus in thoracic radiographs. Clinical signs were suggestive of esoph-
ageal dysfunction in 2 affected IWHs (regurgitation and eructation),
and a fluoroscopic swallow study was performed in these dogs. The
pharyngeal phase was normal, but esophageal transit time was longer
than normal in both dogs.42 In a 2.6-year-old intact male IWH with daily
regurgitation, esophageal transit time was prolonged because of the
food bolus remaining in the cervical esophagus for 10 seconds. In a
5.8-year-old intact female with daily eructation and occasional regurgi-
tation, esophageal transit time was >4 minutes. In this dog, the diame-
ter of the esophagus was estimated as being normal, but peristaltic
waves were completely missing and food material accumulated in the
thoracic esophagus during the entire study period. Both of these dogs
had normal laryngeal function.
3.10 | Follow-up
Two of the 11 affected IWHs were alive 1 year after the study end point
(ages, 9.5 and 4.0 years), and 9/11 dogs had died. The affected dogs had
died at a median age of 7.4 years (range, 3.6-8.3), and 4/9 dogs had died
because of severe BP (other causes of death were neoplasia [4/9] and
hind limb paralysis [1/9]). Recurrent BP had continued after study partici-
pation in all dogs except in 1 dog that was euthanized only 2 months
after study inclusion because of osteosarcoma. Seven of 11 owners
reported a subjective increase in the frequency of BP over time.
4 | DISCUSSION
Recurrent BP recently has been reported as a common disease entity in
IWHs in Sweden and the United Kingdom, but detailed description of
the disease has been lacking.19,21 In our study, affected dogs typically
were free of respiratory signs until they developed the first episode of
BP, which occurred mostly after middle age (median age of onset,
5.0 years). The severity of BP recurrence was indicated by the short
intervals between episodes (median, 3 months) and the fact that approxi-
mately half of affected dogs eventually died or were euthanized because
of BP. However, most of the affected IWHs reached average life expec-
tancy for this breed (reported mean age at death, 6.2-8.2 years) despite
suffering from repeated episodes of BP until death.43,44 A slight female
TABLE 3 Proportions (%) and absolute concentrations (109/L) of peripheral blood lymphocytes expressing specific cell surface markers (CD3,
CD4, CD8, and CD21) in Irish Wolfhounds (IWHs) with recurrent bacterial pneumonia, healthy IWHs, healthy Sighthounds, and in healthy dogs of
other breeds
IWHs with recurrent
bacterial pneumonia Healthy IWHs Healthy Sighthounds
Healthy dogs of
other breeds
n = 11 n = 23 n = 23 n = 16
Mean ± SD
Proportion of lymphocytes (%)
CD3+ 66.1 ± 8.7 68.0 ± 10.3 54.6 ± 14.6 67.8 ± 8.2
CD4+ 46.5 ± 8.7 43.3 ± 8.3 25.9 ± 8.2*** 36.4 ± 6.7**
CD8+ 14.9 ± 5.9 18.1 ± 6.3 22.9 ± 10.9* 23.7 ± 7.8*
CD3+CD4-CD8- 4.6 ± 2.2 6.5 ± 2.4** 5.8 ± 4.3 7.6 ± 2.0***
CD21+ 15.3 ± 5.7 14.9 ± 4.8 18.0 ± 5.8 14.4 ± 5.8
CD4/CD8 ratio 3.7 ± 1.8 2.7 ± 1.2 1.4 ± 0.7*** 1.7 ± 0.7**
Median (IQR)
Concentration of lymphocytes (109/L)
CD3+ 0.74 (0.69-1.23) 0.93 (0.72-1.09) 0.75 (0.52-1.07) 1.55 (1.20-1.84)***
CD4+ 0.58 (0.48-0.75) 0.58 (0.44-0.67) 0.36 (0.26-0.50)*** 0.91 (0.66-1.03)
CD8+ 0.21 (0.10-0.30) 0.21 (0.17-0.31) 0.27 (0.18-0.55) 0.54 (0.34-0.73)***
CD3+CD4-CD8- 0.05 (0.03-0.11) 0.08 (0.06-0.12)* 0.06 (0.03-0.11) 0.19 (0.11-0.23)***
CD21+ 0.19 (0.13-0.27) 0.20 (0.15-0.25) 0.26 (0.17-0.37) 0.27 (0.21-0.50)*
Abbreviation: IQR, interquartile range.
*Significantly different compared with affected IWHs P < .05.; **Significantly different compared with affected IWHs P < .01.; ***Significantly different
compared with affected IWHs P < .001.
FIGURE 1 Bronchoscopic images of Irish Wolfhounds (IWHs) with
recurrent bacterial pneumonia (BP). A, Normal bronchial mucosa in a
0.8-year-old IWH with a history of 2 previous BPs. B, Moderate
bronchial mucosal irregularity in a 5.8-year-old IWH with a history of
6 previous BPs
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predisposition was noted (8/11 were female), although this predisposi-
tion would need to be confirmed in larger studies.
The clinical picture of recurrent BP did not resemble RBPS previ-
ously described in young IWHs: dogs with recurrent BP did not have
clinical signs from a young age, and nasal discharge was only rarely
described during episodes of BP and not at all between episodes.25
Based on these observations, it is likely that recurrent BP represents a
distinct disease entity.
Affected dogs appeared to recover clinically from BP episodes:
they were mostly free of clinical signs between episodes, arterial
PaO2 was normal, and alveolar abnormalities on thoracic radiographs
resolved in most dogs. Bronchoalveolar lavage fluid bacterial and
Mycoplasma spp. cultures did not yield clinically relevant bacterial
growth in any of the dogs between episodes of BP, which also sup-
ports clearance of the infections.45 However, repeated bacterial
cultures during consecutive episodes of BP were not obtained, and
therefore it was not determined that each BP was a new infection
with different causative organisms.
The late onset of clinical signs suggests an acquired rather than
congenital disease. Development of BP generally requires a predispos-
ing factor or event, and in cases of recurrent BP, 1 usually can be identi-
fied.1,2,46 The most common acquired predisposing factors to recurrent
respiratory infections in adult dogs are conditions predisposing to aspi-
ration (mainly laryngeal and esophageal dysfunction).2 Acquired
immune deficits can also commonly contribute to development of
recurrent infections.2 Primary ciliary defects or primary immunodefi-
ciency disorders are unlikely when the onset of clinical signs is at an
older age. However, it has been reported that humans with primary
TABLE 4 The prevalence and characteristics of bronchiectasis (BE) in high-resolution computed tomography studies in Irish Wolfhounds with
recurrent bacterial pneumonia. Bronchiectasis was defined as lack of tapering of the bronchial lumen toward the periphery, identification of
visible bronchi within 1 cm of the lung margin, or a bronchoarterial (BA) ratio exceeding 2.0. Cylindrical BE was characterized as dilatation of the
bronchi without tapering toward the periphery. A saccular BE presented as a focal saccular dilatation or a cyst-like structure, and a varicose BE
was described as a focally dilated bronchial segment interposed between normal
Median (range)
Bronchiectasis detected
Distribution of
bronchiectasis BA ratio Type of bronchiectasis
Right lung
Cranial lobe 5/11 Focal 5/5 2.2 (1.7-3.0) Cylindrical 4/5
Saccular 1/5
Varicose 1/5
Middle lobe 10/11 Focal 8/10 2.6 (2.0-3.7) Cylindrical 10/10
Generalized 2/10
Caudal lobe 0/11
Accessory lobe 0/11
Left lung
Cranial cranial lobe 1/11 Focal 1/1 2.7 Saccular 1/1
Caudal cranial lobe 6/11 Focal 4/6 3.0 (1.6-3.0) Cylindrical 6/6
Generalized 2/6 Varicose 1/6
Caudal lobe 0/11
FIGURE 2 Thoracic computed tomographic images of Irish
wolfhounds (IWHs) with recurrent bacterial pneumonia (BP). A)
Moderate focal bronchiectasis (BE) in the right cranial lung lobe in a
7.0 year old IWH with a history of 4 previous BPs (bronchoarterial
ratio 3.0) B) Moderate BE in the right cranial lung lobe in a 2.6 years
old IWH with a history of 3 previous BPs (bronchoarterial ratio 2.7).
Dogs were scanned in dorsal recumbency.
FIGURE 3 Electron microscopy image of normal ciliary ultrastructure
from an Irish Wolfhound with recurrent bacterial pneumonia. Cilia
exhibit correct number and shape of central and peripheral doublets,
spikes and dynein arms
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immune deficiency may experience the onset of clinical signs in adult-
hood, and a case of ciliary dyskinesia has been reported in an aged
dog.47,48 Therefore, these possibilities also were assessed in our study.
Predisposition to aspiration because of laryngeal or esophageal
dysfunction was identified in some of the affected IWHs and could
have contributed to the development of recurrent BP in these dogs.
However, predisposition to aspiration was not a consistent finding in
affected dogs and the connection between subclinical laryngeal paral-
ysis and recurrent BP was not fully established; comparison with the
prevalence of subclinical laryngeal paralysis in healthy IWHs was not
done. Furthermore, it has been shown previously that laryngeal dys-
function also may be detected under anesthesia in asymptomatic
dogs.29 Retention of food in the esophagus was severe in 1 affected
IWH and was considered the most likely etiology of recurrent BP in
this dog. However, in the other affected IWH with abnormally long
esophageal transit time, only transient retention of the food bolus in
the proximal esophagus was noted.42 The connection of this finding
to recurrent BP is unclear, and it has been reported that proximal
esophageal retention also may occur in healthy dogs.42 On the other
hand, daily regurgitation in this IWH would support the diagnosis of
clinically relevant esophageal hypomotility. One limitation of our study
was that although laryngeal function was assessed under a light plane
of anesthesia, doxapram stimulation was not applied to confirm the
diagnosis. Therefore, it is possible that insufficient laryngeal function
could have been a result of anesthesia-related suppression rather than
true laryngeal paralysis.49 Another limitation of our study was that
esophageal function was assessed only in those dogs in which clinical
signs or findings were suggestive of esophageal dysfunction, and
therefore subclinical esophageal hypomotility cannot be eliminated in
the rest of the dogs. Additionally, the fluoroscopic swallow study was
performed using only canned food. Adding other food consistencies
to the protocol would have been ideal because significant differences
in swallow metrics have been noted among liquid, puree, and kibble
meals.42 However, significant differences in esophageal transit time or
the prevalence of food bolus retention have not been noted, and
therefore adding liquid or kibble to the protocol was considered
unlikely to have changed the assessment.42
Defects in the ciliary ultrastructure suggestive of primary ciliary dys-
kinesia were not detected in any of the affected IWHs. A small number
of compound cilia were commonly noted and most likely represent sec-
ondary changes caused by repeated BP.50 However, normal ultrastruc-
ture of cilia does not fully eliminate a functional deficit; ciliary dyskinesia
without typical ultrastructural changes has been reported rarely in both
humans and dogs.51,52 Ciliary function could be further assessed by using
scintigraphic studies and measuring ciliary beat frequency, but such stud-
ies were not done in our dogs.51,52 However, ciliary dyskinesia was con-
sidered unlikely in these dogs, because the purulent nasal discharge
typical of ciliary dyskinesia was lacking, and accumulation of mucus in
the bronchial tree was not noted during bronchoscopy.6,52–54
Immunoglobulin deficit has been suggested to underlie RBPS in
IWHs and therefore local and systemic immunoglobulin concentra-
tions were evaluated.25,28 However, deficits in systemic or local IgA,
IgG, or IgM were not detected and therefore immunoglobulin defi-
ciency does not explain the recurrent BP.
Flow cytometry analysis of lymphocyte subpopulations did not iden-
tify severe deficits of the common B- and T-cell populations in the
affected IWHs. A significant decrease was noted in the number of CD4
and CD8 negative T lymphocytes when compared with healthy IWHs.
This population of T cells contains small subpopulations including natural
killer T lymphocytes and γδ T lymphocytes.55 Further studies would be
needed to evaluate the concentrations of these individual subpopula-
tions in affected IWHs. Nevertheless, because CD4 negative and CD8
negative T cells were not completely lacking in affected IWHs, and the
concentrations did not differ when compared with healthy Sighthounds,
it was considered unlikely that this finding would explain recurrent infec-
tions. An increased CD4/CD8 ratio detected in affected IWHs likely rep-
resents immunological activation because of repeated infections.56,57
Possible leukocyte adhesion defects (LADs) were not assessed in
our dogs and therefore cannot be eliminated. However, persistent leu-
kocytosis has been reported as a uniform feature in LAD patients and
because IWHs with recurrent BP all had normal leukocyte counts,
LAD was considered unlikely.58–60
Focal BE was a common finding and was detected in all except in
1 affected IWH. Bronchiectasis is a permanent abnormal dilatation of
airways, which contributes to a loss of normal mucociliary clearance. In
humans, BE predisposes to development of bacterial respiratory infec-
tions.61,62 Bronchiectasis in humans develops commonly as a postinfec-
tious consequence of viral or BP but also may be encountered as a
congenital defect or develop secondary to aspiration or a bronchial for-
eign body.62 In dogs, BE has been described in connection with a vari-
ety of infectious and noninfectious respiratory diseases, but the role of
BE as a cause or consequence of BP is not fully established.31,63,64
Local BE was exclusively detected in cranial and ventral lung lobes in
affected IWHs, and because the same lung lobes are mostly affected in
BP, the development of BE likely represents a postinfectious conse-
quence of BP. This conclusion is further supported by the fact that the
only dog in our study without BE was a young dog with only 2 previous
episodes of BP. The severity of BE varied from mild (BA ratio, 2.0-2.5)
to severe (BA ratio, >3.0), and BE is likely to be an important factor pre-
disposing to further infections.31 Similarly, as reported previously, tho-
racic CT examination was more sensitive in detecting BE (10/11) than
was thoracic radiography (0/11) or bronchoscopy (4/11).64 However,
bronchoscopy detected only 40% of the BE confirmed by thoracic CT,
which is less often than previously reported.64 This most likely is
because the bronchoscope provides a limited view of the most cranial
lung areas and cannot access more peripheral airways. In humans, the
prevalence of BE varies among ethnic groups, and it is considered likely
that genetic factors also contribute to the development of BE.62 Fur-
ther studies would be necessary to investigate whether IWHs as a
breed are more predisposed to bronchial remodeling and development
of BE. Because BE likely develops as a consequence of repeated respi-
ratory infections in affected IWHs, prompt and efficient treatment of
acute BP episodes is critical.
The high number of MRSP carriers among affected IWHs sug-
gests that the numerous antimicrobial treatments create a threat of
increasing antimicrobial resistance. This problem is not easily solved.
Because BP is an acute potentially life-threatening bacterial infection,
it needs to be treated with antimicrobials for animal welfare. Because
affected IWHs typically respond rapidly to antimicrobial treatment
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and appear to recover clinically, owners tend to continue treating BP
episodes despite the recurrent nature of the disease. The etiology of
recurrent BPs still is largely unknown, and the methods of prevention,
therefore, also are limited. Future research efforts could be aimed at
identifying possible genetic factors connected with this disease as well
as further investigating possible local immune deficits or factors lead-
ing to marked bronchial remodeling.
An inherent limitation in our study was that episodes of previous
BP were mostly diagnosed and treated by the referring veterinarian
and therefore could not be verified using uniform criteria, and patient
records were available for retrospective review in only 8/11 affected
IWHs. Additionally, healthy IWHs did not undergo all examinations per-
formed in affected dogs and therefore CT, bronchoscopy, and BALF
findings could not be compared with those from the healthy IWHs.
To conclude, recurrent BP affects mostly middle-aged and older
IWHs, and after onset, the disease typically continues with repeated
episodes of BP until death. Focal BE was a frequent finding in affected
dogs, and likely contributes to the development of recurrent respiratory
infections. Additionally, laryngeal dysfunction and esophageal hypomo-
tility were identified as possible predisposing factors to repeated BP in
a minority of dogs. Local or systemic immunoglobulin deficiencies or
primary ciliary defects were not detected in affected dogs.
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